These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 310843)

  • 1. Establishment and characterization of BALB/c lymphoma lines with B cell properties.
    Kim KJ; Kanellopoulos-Langevin C; Merwin RM; Sachs DH; Asofsky R
    J Immunol; 1979 Feb; 122(2):549-54. PubMed ID: 310843
    [No Abstract]   [Full Text] [Related]  

  • 2. Fc IgM receptors on human lymphoblastoid B cell lines.
    Pichler WJ; Broder S; Muul L; Magrath I; Waldmann TA
    Eur J Immunol; 1978 Apr; 8(4):274-8. PubMed ID: 307492
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization and functional properties of tumor cell lines in accessory cell replacement assays.
    Walker EB; Lanier LL; Warner NL
    J Immunol; 1982 Feb; 128(2):852-9. PubMed ID: 7033383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of 2 immunoglobulin isotypes, IgM and IgA, with identical idiotype in the B cell lymphoma I.29.
    Sitia R; Rubartelli A; Hammerling U
    J Immunol; 1981 Oct; 127(4):1388-94. PubMed ID: 6974189
    [No Abstract]   [Full Text] [Related]  

  • 5. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
    Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
    J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosette formation by mouse lymphocytes. II. T-cell specificities in a CRL subpopulation.
    Arnaiz-Villena A; Gyöngyössy MI; Playfair JH
    Clin Exp Immunol; 1974 Oct; 18(2):177-86. PubMed ID: 4219768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a spontaneous murine B cell leukemia (BCL1). I. Cell surface expression of IgM, IgD, Ia, and FcR.
    Knapp MR; Jones PP; Black SJ; Vitetta ES; Slavin S; Strober S
    J Immunol; 1979 Sep; 123(3):992-9. PubMed ID: 313960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine IgA binding factors (IgA-BF) suppressing IgA production: characterization and target specificity of IgA-BF.
    Noro N; Adachi M; Yasuda K; Masuda T; Yodoi J
    J Immunol; 1986 Apr; 136(8):2910-6. PubMed ID: 3514749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface markers in leukemias and lymphomas.
    Siegal FP; Filippa DA; Koziner B
    Am J Pathol; 1978 Feb; 90(2):451-60. PubMed ID: 304673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the nonphagocytic adherent cell from the peritoneal cavity of normal and BCG-treated mice.
    Nathan CF; Asofsky R; Terry WD
    J Immunol; 1977 May; 118(5):1612-21. PubMed ID: 323354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of B cells in vivo by a Fab/Fc fragment of a monoclonal anti-IgD antibody requires an interaction between the antibody fragment and a cellular IgG Fc receptor.
    Goroff DK; Finkelman FD
    J Immunol; 1988 May; 140(9):2919-24. PubMed ID: 2966202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B lymphocytes and macrophages release cell membrane deposited C3-fragments on exosomes with T cell response-enhancing capacity.
    Papp K; Végh P; Prechl J; Kerekes K; Kovács J; Csikós G; Bajtay Z; Erdei A
    Mol Immunol; 2008 Apr; 45(8):2343-51. PubMed ID: 18192019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface markers for lymphocyte subpopulations.
    Stobo JD
    J Lab Clin Med; 1978 Jan; 91(1):9-11. PubMed ID: 304083
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocytes bearing Fc receptor for IgE. VIII. Affinity of mouse IgE for Fc epsilon R on Mouse B lymphocytes.
    Vander-Mallie R; Ishizaka T; Ishizaka K
    J Immunol; 1982 May; 128(5):2306-12. PubMed ID: 6977592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IA mutant functional antigen-presenting cell lines.
    Glimcher LH; Hamano T; Asofsky R; Sachs DH; Pierres M; Samelson LE; Sharrow SO; Paul WE
    J Immunol; 1983 May; 130(5):2287-94. PubMed ID: 6300242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. I. Isolation, characterization, cell surface markers, and B-cell markers.
    Zeuthen J; Klein G; Ber R; Masucci G; Bisballe S; Povey S; Terasaki P; Ralph P
    J Natl Cancer Inst; 1982 Feb; 68(2):179-95. PubMed ID: 6278187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive, I-A-restricted T cell clones.
    Jones B; Tite JP; Janeway CA
    J Immunol; 1986 Jan; 136(1):348-56. PubMed ID: 2415625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between Fc (IgG) receptors and alloantigens on the surface of BALB/c B cell lymphoma lines.
    Kanellopoulos-Langevin C; Kim KJ; Sachs DH; Asofsky R
    J Immunol; 1979 Dec; 123(6):2651-7. PubMed ID: 501085
    [No Abstract]   [Full Text] [Related]  

  • 19. Antigen presentation by normal B cells, B cell tumors, and macrophages: functional and biochemical comparison.
    Chesnut RW; Colon SM; Grey HM
    J Immunol; 1982 Apr; 128(4):1764-8. PubMed ID: 6977567
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of antigen-enriched b cells. I. Purification and response to thymus-independent antigens.
    Snow EC; Vitetta ES; Uhr JW
    J Immunol; 1983 Feb; 130(2):607-13. PubMed ID: 6600244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.